IE37602L - Cyclocpentane derivatives - Google Patents

Cyclocpentane derivatives

Info

Publication number
IE37602L
IE37602L IE720557A IE55772A IE37602L IE 37602 L IE37602 L IE 37602L IE 720557 A IE720557 A IE 720557A IE 55772 A IE55772 A IE 55772A IE 37602 L IE37602 L IE 37602L
Authority
IE
Ireland
Prior art keywords
derivatives
cyclocpentane
novel
ca1077033a
tetranor
Prior art date
Application number
IE720557A
Other versions
IE37602B1 (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3967272A external-priority patent/GB1348036A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IE37602L publication Critical patent/IE37602L/en
Publication of IE37602B1 publication Critical patent/IE37602B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The disclosure relates to novel 17,18,19,20-tetranor-prostanoic acid derivatives having prostaglandin-type properties, to a method for their manufacture, and also to pharmaceutical or veterinary compositions containing said novel derivatives and a method of inducing luteolysis in an animal host by use of said novel derivatives. [CA1077033A]
IE557/72A 1971-05-11 1972-04-27 Cyclopentane derivatives IE37602B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1413971 1971-05-11
GB3967272A GB1348036A (en) 1970-05-15 1972-01-05 Transistorized vertical deflection circuit

Publications (2)

Publication Number Publication Date
IE37602L true IE37602L (en) 1972-11-11
IE37602B1 IE37602B1 (en) 1977-08-31

Family

ID=26235892

Family Applications (1)

Application Number Title Priority Date Filing Date
IE557/72A IE37602B1 (en) 1971-05-11 1972-04-27 Cyclopentane derivatives

Country Status (26)

Country Link
JP (1) JPS5611699B1 (en)
AR (4) AR194952A1 (en)
AT (4) AT328103B (en)
AU (1) AU462755B2 (en)
BE (1) BE783292A (en)
CA (1) CA1077033A (en)
CH (3) CH596165A5 (en)
CS (1) CS192456B2 (en)
DD (1) DD99155A5 (en)
DE (1) DE2223365C3 (en)
DK (1) DK134598B (en)
EG (1) EG10752A (en)
ES (1) ES402627A1 (en)
FI (1) FI63221C (en)
FR (1) FR2137712A1 (en)
HK (1) HK50176A (en)
HU (1) HU166717B (en)
IE (1) IE37602B1 (en)
IL (1) IL39376A (en)
KE (1) KE2634A (en)
NL (1) NL164272C (en)
NO (1) NO139521C (en)
SE (4) SE399705B (en)
SU (1) SU662007A3 (en)
YU (1) YU35876B (en)
ZM (1) ZM8172A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304907A (en) * 1972-05-10 1981-12-08 The Upjohn Company Bicyclo lactone intermediates for prostaglandin analogs
DD118856A5 (en) * 1972-11-08 1976-03-20
US3966795A (en) * 1973-05-21 1976-06-29 The Upjohn Company 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs
US3968144A (en) * 1973-05-21 1976-07-06 The Upjohn Company 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
US4191774A (en) * 1978-01-18 1980-03-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same
US4228296A (en) * 1979-01-24 1980-10-14 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
CS264861B1 (en) * 1986-12-12 1989-09-12 Kral Josef Agent for cow natality increase
CS265947B1 (en) * 1987-06-16 1989-11-14 Kral Josef Means for farming animals' ovarian functions control
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
CS276003B6 (en) * 1988-09-28 1992-03-18 Spolana method of production of (+)-isomer of cloprostenol
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
CN102977048A (en) * 2007-11-09 2013-03-20 阿勒根公司 Substituted cyclopentanes having prostaglandin activity

Also Published As

Publication number Publication date
ATA539073A (en) 1975-05-15
AR194952A1 (en) 1973-08-30
ATA419172A (en) 1976-03-15
NL164272C (en) 1980-12-15
NL7206361A (en) 1972-11-14
ZM8172A1 (en) 1973-01-22
AT328103B (en) 1976-03-10
ATA539173A (en) 1975-05-15
CH596165A5 (en) 1978-02-28
AT333447B (en) 1976-11-25
EG10752A (en) 1976-05-31
KE2634A (en) 1976-06-11
SE7504336L (en) 1975-04-15
DE2223365B2 (en) 1980-07-31
ATA538973A (en) 1975-05-15
NL164272B (en) 1980-07-15
HK50176A (en) 1976-08-13
CH590223A5 (en) 1977-07-29
CS192456B2 (en) 1979-08-31
CA1077033A (en) 1980-05-06
IL39376A0 (en) 1972-07-26
SE7504335L (en) 1975-04-15
DK134598C (en) 1977-05-16
AT328104B (en) 1976-03-10
DE2223365C3 (en) 1981-06-04
FI63221B (en) 1983-01-31
FI63221C (en) 1983-05-10
CH596166A5 (en) 1978-02-28
NO139521B (en) 1978-12-18
YU125072A (en) 1981-02-28
DD99155A5 (en) 1973-07-20
AR200484A1 (en) 1974-11-15
DK134598B (en) 1976-12-06
DE2223365A1 (en) 1972-12-07
IE37602B1 (en) 1977-08-31
SU662007A3 (en) 1979-05-05
YU35876B (en) 1981-08-31
FR2137712B1 (en) 1976-04-16
SE399705B (en) 1978-02-27
JPS5611699B1 (en) 1981-03-16
AR197101A1 (en) 1974-03-15
FR2137712A1 (en) 1972-12-29
AR197100A1 (en) 1974-03-15
SE7504337L (en) 1975-04-15
HU166717B (en) 1975-05-28
ES402627A1 (en) 1975-11-01
IL39376A (en) 1975-07-28
AU4202472A (en) 1973-11-15
BE783292A (en) 1972-11-10
NO139521C (en) 1979-03-28
AT328105B (en) 1976-03-10
AU462755B2 (en) 1975-07-03

Similar Documents

Publication Publication Date Title
IE37602L (en) Cyclocpentane derivatives
IE45439L (en) Penicillanic acid derivatives
GR60385B (en) New propargyl-2-phenylamino-imidazolines-(2),salts thereof by addition of their acids,pharmaceutical mediums containing the above and process for their preparation
AU461619B2 (en) 2, 4, 6-triiodobenzoic acid, compositions for use asx-ray contrast agent and process for their production thereof
CA999236A (en) Process for producing 4-hydroxymethyl-1-keto-1, 2-dlhydrophthalazine and acid salts thereof, and pharmaceutical composition containing the same
CA1008070A (en) 1,4-diazacycloalkane derivatives and acid addition compounds thereof and method of making same
ES436832A1 (en) Prostanoic acid derivatives
CA999857A (en) 8,12-diisoprostanoic acid derivatives and process for their preparation
IL48940A0 (en) Processes for the hydrolysis of acylthio groups,compounds obtained thereby and pharmaceutical or veterinary compositions containing said compounds
AU473287B2 (en) Substituted phenllimida zolidinones, the acid addition salts thereof and processes for their preparation
AU446727B2 (en) New derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
AU463245B2 (en) N, N-dimethyl-O-pyrazolylcarbamic acid esters, process for their preparation and their use as insecticides
CA989837A (en) Methyl-2 dialkylaminomethyl-4(trimethoxy-3'4,5' phenyl) - 2 dioxolanes, its acid added salts, preparation process and therapeutic application
CA1022564A (en) 3-aryl-2-halothiopropionic acid derivatives, their preparation and their use as herbicides
AT318563B (en) Process for the preparation of new 1-amino-2-hydroxy-3- (1 ', 4'-methano- or 1', 4'-ethano-tetrahydronaphthyloxy) -propanes and their acid addition salts
IL38865A0 (en) Penicilloic acid derivatives,their manufacture and pharmaceutical compositions containing them
CA977337A (en) Preparation of 7-d-(2-amino-substituted-acetamido)-3-s-(1,2,3,-triazole-5-yl)-thiomethyl-3-cephem-4-carboxylic acid
CA910323A (en) 1,2,3,11b-tetrahydropyrido(3,4,5:m,n)thioxanthenes, the acid addition salts thereof, and process for the preparation thereof
CA1003831A (en) Salts of an ester of (3-thienyl)-cyclo-hexyl-acetic acid, their preparation and use
CA929532A (en) O.o-dialkyl-s-phenyl-dithiophosphoric acid esters process for their preparation, and their use as insecticides
AU467828B2 (en) Novel 4-thiochromanyl (di)-thiophosphoric and phosphonic acid esters, process for their preparation and their use as pesticides
CA975769A (en) Preparation of 7-d-(2-amino-substituted-acetamido)-3-s-(1,2,3-triazole-5-yl)-thiomethyl-3-cephem-4-carboxylic acid
AU467163B2 (en) 8. 12-diisoprostanoic acid derivatives and process for their preparation
CA868936A (en) Bicyclo-(2.2.2)-octane-1-acetic acid derivatives